Who has invested in Totus Medicines?

DCVC Bio are named among the investors backing Totus Medicines.

Totus Medicines Funding: $107M Raised, Series B (2023)

Totus Medicines funding overview

Totus Medicines is based in Emeryville. Totus Medicines has raised $107M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in December 2023. The round record for Totus Medicines runs through 2023; nothing later has been disclosed. Investors on record include DCVC Bio.

Totus Medicines at a glance

Total raised: $107M
Latest round: Series B
Latest round date: December 2023
Headquarters: Emeryville
Notable investors: DCVC Bio

Frequently asked about Totus Medicines funding

How much has Totus Medicines raised?: Totus Medicines has raised $107M in total disclosed funding across the rounds on record.
Who has invested in Totus Medicines?: DCVC Bio are named among the investors backing Totus Medicines.
What was the latest Totus Medicines funding round?: The most recent disclosed round is a Series B, announced in December 2023.
Where is Totus Medicines based?: Totus Medicines is based in Emeryville.
When did Totus Medicines last raise?: The last disclosed Totus Medicines round closed in December 2023 at Series B.

Totals shown for Totus Medicines aggregate every disclosed round on file. To see how that compares, browse the companies in Emeryville and the investors behind them below.

Totus Medicines Funding: $107M Raised, Series B (2023)

Totus Medicines funding overview

Totus Medicines at a glance

Frequently asked about Totus Medicines funding

Companies related to Totus Medicines (34)

Browse related funding lists (4)